Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleDecitabine.AuthorsGore, Steven D.; Jones, Carole; Kirkpatrick, PeterAbstractDecitabine (Dacogen; MGI Pharma), a nucleoside analogue that inhibits DNA methylation, was approved by the US FDA for the treatment of myelodysplastic syndromes in May 2006.SubjectsNUCLEOSIDES; METHYLATION; MYELODYSPLASTIC syndromes; UNITED States. Food &; Drug Administration; MGI Pharma Inc.; GENE therapy; THERAPEUTICSPublicationNature Reviews Drug Discovery, 2006, Vol 5, Issue 11, p891ISSN1474-1776Publication typeArticleDOI10.1038/nrd2180